- Home
- ANIK vs GALT Comparison
ANIK vs GALT Comparison
Compare ANIK & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIK | GALT |
|---|---|---|
| Founded | 1983 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.3M | 176.7M |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ANIK | GALT |
|---|---|---|
| Price | $12.69 | $3.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $16.00 | $8.50 |
| AVG Volume (30 Days) | 140.9K | ★ 216.3K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $119,907,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.79 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.90 | $1.15 |
| 52 Week High | $17.74 | $7.13 |
Technical Indicators
Market Signals| Indicator | ANIK | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 82.44 | 50.31 |
| Support Level | $10.62 | $2.90 |
| Resistance Level | $15.10 | $3.24 |
| Average True Range (ATR) | 0.41 | 0.19 |
| MACD | 0.17 | 0.09 |
| Stochastic Oscillator | 94.61 | 73.24 |
Price Performance
Historical ComparisonAbout ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.